Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Anteris Technologies Global Corp. AVR | Sio Capital Management LLC | 3,464,965 9.620% | -40 (-0.00%) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 276,603 5.040% | -3,397 (-1.21%) | Filing History |
| 2025-04-08 3:14 pm Purchase | 2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG | Sio Capital Management LLC | 507,562 7.210% | 55,769 (+12.34%) | Filing History |
| 2025-04-08 3:14 pm Purchase | 2025-03-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Sio Capital Management LLC | 3,735,396 7.190% | 163,229 (+4.57%) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Q32 Bio Inc. QTTB | Sio Capital Management LLC | 0 0.000% | -697,413 (Position Closed) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Vaxart, Inc. VXRT | Sio Capital Management LLC | 5,583,448 2.450% | -5,931,867 (-51.51%) | Filing History |
| 2025-04-08 3:14 pm Sale | 2025-03-31 | 13G | Ventyx Biosciences, Inc. VTYX | Sio Capital Management LLC | 2,582,655 3.630% | -1,464,142 (-36.18%) | Filing History |
| 2025-02-10 12:59 pm Purchase | 2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | Sio Capital Management LLC | 4,046,797 5.720% | 4,046,797 (New Position) | Filing History |
| 2025-02-10 12:58 pm Purchase | 2024-12-31 | 13G | Vaxart, Inc. VXRT | Sio Capital Management LLC | 11,515,315 5.060% | 11,515,315 (New Position) | Filing History |
| 2025-02-10 12:58 pm Purchase | 2024-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Sio Capital Management LLC | 3,572,167 6.900% | 3,572,167 (New Position) | Filing History |
| 2025-02-10 12:57 pm Purchase | 2024-12-31 | 13G | Q32 Bio Inc. QTTB | Sio Capital Management LLC | 697,413 5.730% | 697,413 (New Position) | Filing History |
| 2025-02-10 12:57 pm Purchase | 2024-12-31 | 13G | Anteris Technologies Global Corp. AVR | Sio Capital Management LLC | 3,465,005 9.640% | 3,465,005 (New Position) | Filing History |
| 2025-02-10 12:57 pm Sale | 2024-12-31 | 13G | Modular Medical, Inc. MODD | Sio Capital Management LLC | 251,990 0.730% | -1,858,270 (-88.06%) | Filing History |
| 2025-02-10 12:56 pm Purchase | 2024-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 276,603 5.090% | 276,603 (New Position) | Filing History |
| 2025-02-10 12:56 pm Purchase | 2024-12-31 | 13G | Bright Minds Biosciences Inc. DRUG | Sio Capital Management LLC | 451,793 6.500% | 451,793 (New Position) | Filing History |
| 2024-02-14 08:00 am Purchase | 2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE | Sio Capital Management LLC | 280,000 7.490% | 280,000 (New Position) | Filing History |
| 2024-02-14 08:00 am Purchase | 2023-12-31 | 13G | Modular Medical, Inc. MODD | Sio Capital Management LLC | 2,110,260 9.990% | 2,110,260 (New Position) | Filing History |
| 2024-02-14 08:00 am Purchase | 2023-12-31 | 13G | Gracell Biotechnologies Inc. GRCL | Sio Capital Management LLC | 25,007,900 5.200% | 25,007,900 (New Position) | Filing History |
| 2023-02-13 1:24 pm Purchase | 2022-12-31 | 13G | Modular Medical, Inc. MODD | Sio Capital Management LLC | 1,091,479 9.990% | 1,091,479 (New Position) | Filing History |
| 2022-02-10 4:05 pm Sale | 2021-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | Sio Capital Management LLC | 6,771 3.000% | -1,515 (-18.28%) | Filing History |